skip to Main Content

Vaccines / Preventive Services

Adult immunization rates are falling short of national targets. Learn how global, federal, and state policies affect vaccination uptake. Leverage our findings to guide your strategies. Rely on our expertise commercializing novel and therapeutic vaccines. Visit our COVID-19 Intel Center to decipher the facts and plan for downstream business implications.

Medicare Spent $106B on Vaccine-Preventable Diseases Over 3 Years

Avalere analysis finds Medicare incurred $106.4 billion in 2016–2018 treating diseases potentially preventable with inline vaccines and select pipeline vaccine candidates. Those diseases also resulted in beneficiary costs of approximately $9.6 billion during the same time period.

Sign up to receive more insights about Vaccines / Preventive Services
Please enter your email address to be notified when new Vaccines / Preventive Services insights are published.

Back To Top